No Cost for COVID–19 Testing Act

House Bill 6213 - No Cost for COVID–19 Testing Act: Overview, Status, and Impact

Hozzl · 2022-02-09T01:57:10Z

Explore the details of House Bill 6213 No Cost for COVID–19 Testing Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/9/2022, 1:57 AM

Congressional Summary of HR 6213

No Cost for COVID–19 Testing Act

This bill requires private health insurance plans to cover testing for COVID-19 (i.e., coronavirus disease 2019) without imposing cost sharing for the duration of the public health emergency declared on January 31, 2020. This includes the cost of administering such approved tests and visits to health care providers for testing.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 6213

Bill HR 6213 is currently in the status of Bill Introduced since March 11, 2020. Bill HR 6213 was introduced during Congress 116 and was introduced to the House on March 11, 2020. Bill HR 6213's most recent activity was Referred to the Subcommittee on Health. as of March 11, 2020

Bipartisan Support of Bill HR 6213

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 6213

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health

- Emergency medical services and trauma care

- Employee benefits and pensions

- Health care costs and insurance

- Health care coverage and access

- Infectious and parasitic diseases

- Medical tests and diagnostic methods

Alternate Title(s) of Bill HR 6213

No Cost for COVID–19 Testing Act

To provide for coverage (without cost sharing or utilization management requirements) under group health plans and individual and group health insurance coverage of testing for COVID-19.

No Cost for COVID–19 Testing Act